TIGIT acts as an immune checkpoint upon inhibition of PD1 signaling in autoimmune diabetes
IntroductionChronic activation of self-reactive T cells with beta cell antigens results in the upregulation of immune checkpoint molecules that keep self-reactive T cells under control and delay beta cell destruction in autoimmune diabetes. Inhibiting …